Amphastar Pharmaceuticals Inc vs FMC Corp — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.63 (market cap $868.62M), while FMC Corp trades at $10.21 (market cap $1.30B). The key difference: FMC Corp is the larger of the two by market cap, and FMC Corp pays a 3.07% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | FMC | |
|---|---|---|
Market Cap | $868.62M | $1.30B |
Sector | Health | Basic Materials |
52-Week High | $30.81 | $40.69 |
52-Week Low | $16.87 | $10.01 |
Enterprise Value | $1.27B | $5.11B |
Dividend Yield | — | 3.07% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FMC stock trades at $10.46, down 1.23% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $2.24 billion in 2025, with negative profitability margins, though recent quarters show mixed earnings beats. Analyst consensus is divided, with a $11.60 price target, while recent news highlights revenue challenges and strategic moves like a $400 million investment from Tessenderlo Group to reduce debt.
The outlook remains cautious due to persistent losses and weak revenue trends, but debt reduction efforts and cost controls offer some stability. Key risks include competitive pressures and macroeconomic headwinds, while the current valuation metrics like P/S of 0.4 may attract value investors if operational improvements materialize.
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →